Results 211 to 220 of about 1,220,527 (364)

BP/MoS₂ Van Der Waals Heterojunctions for Self‐Powered Photoconduction [PDF]

Adolfo Mazzotti, O. Durante, S. De Stefano, Loredana Viscardi, Aniello Pelella, Osamah Kharsah, Leon Daniel, Stephan Sleziona, Marika Schleberger, Antonio Di Bartolomeo   +9 more
openalex   +1 more source

TCAD as a tool for the interpretation of Terahertz Rectification in MOS-FET

, 2021
F. Palma
openalex   +2 more sources

Production of $D^{(*)}{\overline{D}}^{(*)}$ near the thresholds in $e^{+}{e}^{-}$ annihilation

Physical Review
It is shown that the nontrivial energy dependencies of DD¯, DD¯*, and D*D¯* pair production cross sections in e+e− annihilation are well described within the approach based on an account of the final-state interaction of produced particles. This statement is valid for the production of charged and neutral particles.
Salnikov, S. G., Milstein, A. I.
openaire  

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Concurrent Validity and Inter-Rater Reliability of the Motor Optimality Score-Revised in a Neonatal Surgical Population. [PDF]

J Clin Med
Crowle C, Jackman M, Luke C, Webb A, Juarez M, Korostenski L, Zawada K, Blatch-Williams R, Morgan C.   +8 more
europepmc   +1 more source

Field‐Effect Transistors: Contact‐Engineered Electrical Properties of MoS₂ Field‐Effect Transistors via Selectively Deposited Thiol‐Molecules (Adv. Mater. 18/2018) [PDF]

, 2018
Kyungjune Cho, Jinsu Pak, Jae‐Keun Kim, Keehoon Kang, Taeyoung Kim, Jiwon Shin, Barbara Yuri Choi, Seungjun Chung, Takhee Lee   +8 more
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Advances in materials engineering of CdS coupled with dual cocatalysts of graphene and MoS₂for photocatalytic hydrogen evolution

, 2018
Nan Zhang, Shao‐Hai Li, Xianzhi Fu, Yi‐Jun Xu   +3 more
openalex   +1 more source

MOS volume 21 Cover and Front matter [PDF]

, 1966

openalex   +1 more source